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Necessity for Excellent Glycemic Control Before, During and After CABG Surgery
Sheri Clouse, RN, CDE, Diabetic Education Coordinator at Marion General Hospital
Otterbein University, Westerville, Ohio
Case Study
A 72 year old male patient was admitted to
the hospital presenting with sharp substernal pain and pressure to the left upper
chest rated a “10” out of 10. Patient
complained of chest pain even at rest
which was relieved by a nitroglycerin
infusion. Patient had established coronary
artery disease as evidenced by five prior
stent placements, with the last stent
placement being in 2010. The patient also
presented to the Emergency Room with a
blood glucose level over 600 mg/dL and
because of his complaints of chest pain,
was transferred to a neighboring hospital
facility to have a cardiac catheterization
procedure. Past medical history included:
uncontrolled type 2 diabetes with an A1c
value of 10.0 %, coronary artery disease,
hyperlipidemia, hypertension,
gastroesophageal reflux disease (GERD),
and osteoarthritis. Cardiac catheterization
procedure was performed and
recommendation for him to have open
heart surgery due to three vessels being
90-100% occluded was given. Patient
underwent three vessel coronary artery
bypass graft procedure (CABG) the
following week and was discharged to an
extended care facility (ECF) for
rehabilitation another week later after
having difficulty managing blood sugars
under 225 mg/dL. Other postoperative
course in the hospital was unremarkable
and uneventful.
One week later, the patient was readmitted to the hospital with blood sugars
in the 400 mg/dL range and complaints of
increased soreness to the chest in the
incision area. The sternal wound showed
signs of dehiscence to the point of
stretching the sternal wires. After two
days of antibiotic therapy, patient
underwent mediastinal exploration with
removal of sternal wires and sternal plate,
and an advanced pectoralis flap surgery
was performed. Patient returned to the
ECF for rehabilitation after being medically
stabilized. Two months later, the patient
was re-admitted to the hospital for signs
and symptoms of wound infection. After
antibiotic treatment, the patient returned
to the ECF for the remainder of
rehabilitation.
Unfortunately, this is a true case study and
occurs in many facilities across the
country. What could have been done
differently to facilitate a better outcome?

Introduction
The stress of surgery has often been
explained as a major factor in patients
experiencing hyperglycemia in the acute
hospital setting. Quantifying the effects
of poor glycemic control in hospitalized
patients is often difficult. Numerous
studies have been conducted to focus on
better blood sugar management for
medically hospitalized patients, but far
fewer have been conducted to show the
poor outcomes from hyperglycemia with
surgical patients. In many patients, the
stress of surgery can cause high blood
sugars due to increased stress hormones
such as epinephrine and norepinephrine.
Growth hormone, glucagon,
gluconeogenesis, and cortisol levels also
increase under stressful conditions
contributing to a worsening
hyperglycemic state. Another problem
that arises is a decrease in insulin levels
due to reduced secretion from the
pancreas and increased insulin
resistance at the receptor sites on muscle
cells (Raju, Torjman, & Goldberg, 2009,
p. 1283).
A study conducted by the Department of
Endocrinology at Boston University
Medical Center was able to surmise that
up to 80% of patients that had cardiac
surgery developed high blood sugars
over 200 mg/dL at some point in the
surgical process. This suggests
prolonged length of stay and increased
hospital costs (Alexanian, McDonnell, &
Akhtar, 2011, p. 1).
Another study conducted by the
Department of Cardiothoracic Surgery at
The Boston Medical Center states that up
to 40 % of patients having a coronary
artery bypass graft procedure (CABG)
already have a diagnosis of either
diabetes or metabolic syndrome. These
patients are at very high risk of needing
repeat procedures and hospitalizations
due to poor healing and increased
infection of the incisions to the chest and
to the sites of the graft vessels (Lazer,
2012, p. 1).
The goal of this poster presentation is to
demonstrate how excellent glycemic
control before, during, and after
coronary artery bypass graft procedure
can dramatically decrease mortality and
morbidity for these patients.

Detrimental Effects
In normal heart function, the main energy
source for the non-ischemic myocardium is free
fatty acids. During ischemic events, free fatty
acids can no longer be used as the
myocardium’s energy source, and so, glucose is
chosen. In diabetic patients who are already
insulin resistant, impaired glucose metabolism
leads to increased serum glucose levels.
Increased levels of free fatty acids due to
ischemia increases oxygen use, creates insulin
resistance, decreases pumping ability, increases
risk of lethal arrhythmias, increases risk for
thrombus and plaque rupture, and impairs
function of platelets. An increased blood sugar
over 250 mg/dL can place a patient at a 10-fold
increase of complications after surgery (Lazer,
2012, p. 1-2).
Hyperglycemia impairs wound healing by
hindering collagen production leading to
decreased strength in the surgical wound
placing the patient at high risk for dehiscence.
Infection risk is increased due to impairment of
leukocyte phagocytosis and chemotaxis (Lynn
Gieger, 2009, p. 12). During surgery, insulin
requirements increase due to increased insulin
resistance caused by hypothermia, increased
glucose from cardioplegic solution, and
inotropic support.
All of these factors combined place the diabetic
patient at extreme risk of wound dehiscence,
infected incision, and sepsis thereby increasing
the risk of mortality (Lazer, 2012, p. 4). Medical
staff must be vigilant in excellent blood sugar
control to prevent these complications.

Implications for Nursing
Nurses play a vital role in the management of the insulin infusion in the ICU setting.
According to the hospital’s algorithm, titration of the infusion rate is managed by
hourly blood sugar measurements. Nurses must be knowledgeable in the management
of diabetic patients as often, their needs for insulin change in the postoperative setting.
Staff education regarding management of the insulin infusion, parameters for expected
blood sugar values, and when to notify the physician should be completed. Patient
education must be performed at every juncture within the surgery process.
Instruction is given during pre-admission testing as to whether to give or hold home
oral hyperglycemics as well as how much of the insulin dose to be given 24 hours prior
to surgery. Sternal precautions need to be taught and reinforced throughout the
hospital stay. Lastly, prior to discharge, the bedside nurse gives instruction regarding
home medications to be taken , dietary regimen, and frequency of blood sugar
measurements to be recorded.

Conclusion
.

Role of Insulin During CABG Procedure
IV insulin during CABG surgery and the post-operative period is the preferred choice
of correction of increased blood sugars due to its short half-life and rapid action. IV
insulin should be maintained for at least 24 hours after surgery to ensure the best
blood sugar management (Alexanian, McDonnell, & Akhtar, 2011, p. 2). Studies show
that insulin encourages myocardial glucose uptake, inhibits release of free fatty acids,
and reverses the harmful effects of oxidative stress caused by hyperglycemia on the
myocardium. Insulin has also been shown to better preserve the neutrophil’s
phagocytic function which can aid in reduction of wound infections often seen in
diabetic CABG patients (Lazer, 2012, p. 2) Metformin is recommended to be
discontinued for 48 hours prior to surgery and not restarted until kidney function is
optimal. Metformin can increase the risk for lactic acidosis in the intraoperative period
(Raju, Torjman, & Goldberg, 2009, p. 1283). IV insulin can be used in lieu of
metformin throughout the hospital stay. The guidelines to postpone CABG surgery
due to poor blood sugar control has not been established at this time. Surgeons and
medical staff must consider several factors including: urgency of surgery, overall
health of the patient, and metabolic status to ensure the best possible outcome for the
diabetic cardiac patient (Alexanian, McDonnell, & Akhtar, 2011, p. 2). The blood sugar
goal to best ensure optimal healing is under 180 mg/dL and most easily attained by IV
insulin infusion (Lazar, et al., 2009, p. 3).

Other Factors Causing Dysfunction in Blood
Sugar Management
Cardioplegic solution often used to paralyze the heart in order to perform CABG
surgery contains amino acids, MSG (Monosodium glutamate), MSA (monosodium
aspartate), CPD (Citrate Phosphate Dextrose Solution), Dextrose, Thromethamine, and
KCL. The dextrose present in cardioplegic solution serves as a substrate for glycolysis
to supply the myocardium during the bypass procedure, however, the additional
glucose load leads to increased hyperglycemia and insulin resistance in the already
compromised diabetic heart (Minasian, Galagudza, Dmitriev, Kurapeev, & and Vlascov,
2013, p. 3).
1—Principal mechanisms responsible for endothelial dysfunction in diabetes. NO is the principal anti-atherosclerotic
endothelium-derived mediator. It is formed from L-arginine by eNOS, being tetrahydrobiopterin (BH4), a crucial cofactor for the
reaction. Endothelial dysfunction is defined by the presence of a reduced NO bioavailability. In the presence of diabetes,
characterized by the existence of insulin resistance and hyperglycemia, endothelial dysfunction is due to both reduced production
(increased circulating levels of the eNOS endogenous inhibitor asymmetric dimethylarginine [ADMA], decreased cellular levels of
BH4 and decreased eNOS activation) and to an increased breakdown of NO by ROS. AGEs, advanced aging end products; FFA,
free fatty acids (Versari, Daghini, Virdis,Ghiadoni, & Taddei, 2009 pS314.

Hyperglycemia during CABG and cardiac procedures
increases the likelihood of complications caused by
increased release of free fatty acids, inflammation and
oxidative vascular stress. Poor neutrophil phagocytic
function and decreased collagen production in the sternal
wound leads to increased risk for infection and wound
dehiscence in the post-operative phase. Insulin infusion
during the procedure, and 24 hours post procedure, helps
ensure blood sugar management under 180 mg/dL,
where experts have determined the point of lowest risk
for complications during recovery. Nurses are pivotal in
the role of insulin infusion management in the ICU.
Nurses, physicians, and other supportive personnel need
to work together to promote the environment that
excellent glycemic control is necessary in the
management of diabetic patients before, during, and after
CABG and cardiac procedures to ensure the best
outcomes for their patients.
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Summary of the healing process.
Intermediate phase of the repair reaction.
(A) As a new extracellular matrix is deposited
at the wound site, the initial fibrin clot is
lysed by a combination of extracellular
proteolytic enzymes and phagocytosis.
(B) Concurrent with fibrin removal, there is
deposition of a temporary matrix formed by
proteoglycans, glycoproteins, and type III
collagen.
(C) Final phase of the repair reaction.
Eventually the temporary matrix is removed
by a combination of extracellular
and intracellular digestion, and the
definitive matrix, rich in type I collagen, is
deposited.
Reproduced with permission from: Rubin E,
Farber JL. Pathology, 3rd Edition.
Philadelphia: Lippincott Williams & Wilkins,
1999. Copyright © 1999 Lippincott Williams
& Wilkins.
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